Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

Journal of Clinical Oncology

Volumn 31, Issue 12, 2013, Pages 1539-1547

  Martin, Lisa ^a   Birdsell, Laura ^a   MacDonald, Neil ^b   Reiman, Tony ^c   Clandinin, M Thomas ^a   McCargar, Linda J ^a   Murphy, Rachel ^a   Ghosh, Sunita ^a   Sawyer, Michael B ^a   Baracos, Vickie E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CACHEXIA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SKELETAL MUSCLE; UNDERWEIGHT; WEIGHT REDUCTION;

ADULT; AGE FACTORS; AGED; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; CANADA; CANCER CARE FACILITIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM STAGING; OBESITY; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84876581806     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.2722     Document Type: Article

References (33)

1. Dewys WD, Begg C, Lavin PT, et al: Prognostic effect of weight loss prior to chemotherapy in cancer patients: Eastern Cooperative Oncology Group. Am J Med 69:491-497, 1980 (Pubitemid 10018703)
2. National Institutes of Health, National Cancer Institute: Common Terminology Criteria for Adverse Eventsversion4.0(CTCAE).http://www.eortc.be/ services/doc/ctc/CTCAE-4.03-2010-06-14-QuickReference-5x7. pdf
3. Tjepkema M: Measured obesity: Adult obesity in Canada - Measured height and weight. http://www.aboutmen.ca/application/www.aboutmen.ca/asset/upload/ tiny-mce/page/link/Adult-Obesity-in- Canada.pdf
4. Flegal KM, Carroll MD, Ogden CL, et al: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241, 2010
5. Blum D, Omlin A, Baracos VE, et al: Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80:114-144, 2011
6. Spiro A, Baldwin C, Patterson A, et al: The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95:431-434, 2006 (Pubitemid 44232550)
7. Bouillanne O, Morineau G, Dupont C, et al: Geriatric Nutritional Risk Index: A new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82:777-783, 2005 (Pubitemid 43779690)
8. Guigoz Y, Vellas B, Garry PJ: Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 54:S59-S65, 1996 (Pubitemid 26110669)
9. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10:433-442, 2007 (Pubitemid 46934112)
10. Baumgartner RN: Body composition in healthy aging. Ann N Y Acad Sci 904:437-448, 2000 (Pubitemid 30389235)
11. Prado CM, Lieffers JR, McCargar LJ, et al: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A populationbased study. Lancet Oncol 9:629-635, 2008
12. Fearon K, Strasser F, Anker SD, et al: Definition and classification of cancer cachexia: An international consensus framework. Lancet Oncol 12: 489-495, 2010
13. Delmonico MJ, Harris TB, Lee JS, et al: Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55:769- 774, 2007 (Pubitemid 46668965)
14. McCalllum PD: Patient-generated subjective global assessment, in McCallum PD, Polisena C (eds): The Clinical Guide to Oncology Nutrition. Chicago, IL, American Dietetic Association, 2000, pp 11-23
15. Perry GS, Byers TE, Mokdad AH, et al: The validity of self-reports of past body weights by U.S. adults. Epidemiology 6:61-66, 1995
16. Payette H, Kergoat MJ, Shatenstein B, et al: Validity of self-reported height and weight estimates in cognitively-intact and impaired elderly individuals. J Nutr Health Aging 4:223-228, 2000 (Pubitemid 32044696)
17. Martin L, Watanabe S, Fainsinger R, et al: Prognostic factors in patients with advanced cancer: Use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28: 4376-4383, 2010
18. Mourtzakis M, Prado CM, Lieffers JR, et al: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997-1006, 2008
19. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al: Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85:115- 122, 1998 (Pubitemid 28334913)
20. Shen W, Punyanitya M, Wang Z, et al: Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol 97:2333-2338, 2004 (Pubitemid 39552474)
21. Irving BA, Weltman JY, Brock DW, et al: NIH image and Slice-O-Matic computed tomography imaging software to quantify soft tissue. Obesity (Silver Spring) 15:370-376, 2007 (Pubitemid 46407318)
22. Williams BA, Mandrekar JA, Mandrekar SJ, et al: Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Rochester, MN, Mayo Foundation, Technical Report Series 79, 2006
23. Harrell FE Jr., Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996 (Pubitemid 26072233)
24. Hosmer DW, Lemeshow S: Applied Logistic Regression (ed 2). New York, NY, John Wiley and Sons, 2000
25. Pencina MJ, D'Agostino RB: Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 23:2109-2123, 2004 (Pubitemid 38968032)
26. Lieffers JR, Baracos VE, Winget M, et al: A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 117:1957-1965, 2011
27. Quinten C, Coens C, Mauer M, et al: Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865-871, 2009
28. Prado CM, Baracos VE, McCargar LJ, et al: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264-3268, 2007 (Pubitemid 46944911)
29. Prado CM, Baracos VE, McCargar LJ, et al: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920-2926, 2009
30. Antoun S, Baracos VE, Birdsell L, et al: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21:1594-1598, 2010
31. Cosqué ric G, Sebag A, Ducolombier C, et al: Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895-901, 2006 (Pubitemid 46454567)
32. McMillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223-226, 2009
33. Miljkovic I, Zmuda JM: Epidemiology of myosteatosis. Curr Opin Clin Nutr Metab Care 13:260- 264, 2010